Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Fiona O'Neill
Dublin City University
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
50
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Neratinib Plus Dasatinib is Highly Synergistic in Her2-Positive Breast Cancer Models
Number of pages: 36
Posted: 08 Mar 2024
Neil Conlon
,
Sandra Roche
,
Amira Mahdi
,
Alacoque Browne
,
Laura Breen
,
Johanna Gaubatz
,
Justine Meiller
, Fiona O'Neill,
Lorraine O'Driscoll
,
Mattia Cremona
,
Bryan Hennessy
,
Lisa Eli
,
John Crown
and
Denis M. Collins
Dublin City University, Dublin City University, Dublin City University, Dublin City University, Dublin City University, Dublin City University, Dublin City University, Dublin City University, Trinity College (Dublin), Royal College of Surgeons in Ireland (RCSI), Royal College of Surgeons in Ireland (RCSI), Puma Biotechnology Inc., Dublin City University and Dublin City University
Downloads
50
(1,097,529)
View PDF
Download
Abstract:
Breast cancer, HER2-positive, Targeted therapies, Neratinib, Dasatinib
Feedback
